Understanding how cells respond to mechanical signals
New insights into the molecular regulation of mechanotransduction
This study is looking at how cells feel and react to physical signals around them, which is important for things like movement and tissue growth, and it hopes to find out more about how this process can be linked to diseases like asthma, cancer, and heart problems.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts Institute of Technology NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-10472251 on NIH RePORTER |
What this research studies
This research investigates the process of mechanotransduction, which is how cells sense and respond to mechanical signals in their environment. It focuses on the role of integrin receptors and focal adhesions in this process, which are crucial for cell movement and tissue development. By studying how these structures form and function, the research aims to uncover the molecular mechanisms that can lead to diseases like asthma, cancer, and heart failure. The approach includes cell-based experiments to explore the composition and regulation of focal adhesions.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who have conditions like asthma, cancer, or cardiovascular diseases.
Not a fit: Patients with conditions unrelated to mechanotransduction or those under 21 years old may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for diseases related to abnormal cell signaling, such as asthma and cancer.
How similar studies have performed: Previous research has shown promising results in understanding mechanotransduction, indicating that this approach could lead to significant advancements.
Where this research is happening
Cambridge, United States
- Massachusetts Institute of Technology — Cambridge, United States (Active)
Researchers
- Principal investigator: Case, Lindsay — Massachusetts Institute of Technology
- Study coordinator: Case, Lindsay
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.